search
Back to results

Chronic Coronary Syndrome in Swedish Primary Care (COSPRI)

Primary Purpose

Coronary Artery Disease

Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Package investigation
Sound registration with Cadscore® and added risk calculation
Standard investigation
Sponsored by
Region Östergötland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Coronary Artery Disease focused on measuring Primary Health Care, Diagnostic Imaging, Myocardial Perfusion Imaging

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: • People who seek primary care for symptoms judged to be compatible with a medium probability (PTP> 15) for symptomatic chronic coronary artery disease. Exclusion Criteria: Suspicion of acute coronary syndrome when care is sought. Previously diagnosed acute myocardial infarction Revascularization with PCI/CABG Proven reversible ischemia according to myocardial scintigraphy. Left Bundle Branch Block (LBBB). Ventricular pacemaker People whose meaning due to illness, mental disorder, weakened state of health or any other similar condition cannot be obtained, to be included in a research project. Insufficient understanding of spoken and written Swedish language.

Sites / Locations

  • Department of Clinical Physiology, Linköping University Hospital, LinköpingRecruiting
  • Hjärthälsan Linköping AB
  • Department of Clinical Physiology, Vrinnevi HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Package investigation

Standard investigation

Arm Description

Resting ECG, Evaluation of risk according to PTP-table. Echocardiography, Exercise stress bicycle test (secondarily drug provocation) with injection of isotope for myocardial scintigraphy, Scanning for myocardial perfusion CAC-scoring with CT

Resting ECG Evaluation of risk according to PTP-table. Echocardiography. Exercise stress bicycle test. If judged to be needed according to clinical indication sequentially completed by: Echocardiography, Exercise stress bicycle test (secondarily drug provocation) with injection of isotope for myocardial scintigraphy and/or Coronary CTA. In addition, cardiac examinations done with other modalities chosen on clinical grounds will be examined in the study. ,

Outcomes

Primary Outcome Measures

Number of days till completed assessment of myocardial ischemia
waiting time (days) after the results of package investigation or exercise stress bicycle test (standard investigation) are available at the primary health care center till invasive coronary angiography is done or results from completed non-invasive myocardial ischemia investigation is communicated to the participant (patient).

Secondary Outcome Measures

Swedish crowns or other currency
Costs for medical investigations, consultations and costs generated by participants loss of production and travel costs. Data will be gathered by review of the participants computerized medical records one year after the day of inclusion. Medical investigations will be sought in local medical registries.The participant will be asked if being a professional worker or not on the day of inclusion.
Health related quality of life
Health related quality of life will be measured by EQ-5D-5L Swedish version (Devlin NJ et al., 2017)
Radiation per patient
millisievert (mSv)
Physical activity
Physical activity will be measured by two categorical questions asking for level of physical activity (Olsson SJ et al., 2016)
Dietary habits
Dietary habits will be measured by five categorical questions about consumption of fruit, vegetables, snacks and soft drinks during the last week. (Henriksson H et al., 2020)
Health and life quality
Health and life quality will be measured by the Swedish RAND-36 A 36-item scale. (Ohlsson-Nevo E et al., 2021)
Heart focused anxiety
Heart focused anxiety will be measured by the Cardiac Anxiety Questionnaire - CAQ An 18-item scale (Eifert et al., 2000)
Generalized anxiety
Generalized anxiety will be measured by the Brief Measure for Assessing Generalized Anxiety Disorder - GAD-7 A seven item scale. (Spitzer et al., 2006)
Depression symptoms
Depression symptoms will be measured by the Patient Health Questionnaire - PHQ-9 Maximum score 27 (Hansson et al., 2009)
Sleep quality
Sleep quality will be measured by The Pittsburgh Sleep Quality Index - PSQI A 19-item scale which assesses sleep quality and disturbances over a 1-month time interval. (Buysse et al., 1989)
Physical fitnes
Physical fitness will be measured by The International Fitness Scale - IFIS A 5-item scale (Ortega FB et al., 2011)
MACE
Major adverse cardiovascular event - MACE Data will be gathered from national Swedish registries i.e. SWEDEHEART, the National Patient Register and Dödsorsaksregistret (The Cause of Death Register)
Compliance to cardioprotective drugs
Data on prescribed and purchased drugs will be gathered from the National Prescribed Drug Register .

Full Information

First Posted
March 11, 2023
Last Updated
July 8, 2023
Sponsor
Region Östergötland
Collaborators
Linkoeping University
search

1. Study Identification

Unique Protocol Identification Number
NCT05782582
Brief Title
Chronic Coronary Syndrome in Swedish Primary Care
Acronym
COSPRI
Official Title
Chronic Coronary Syndrome in Swedish Primary Care
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 1, 2023 (Actual)
Primary Completion Date
April 30, 2026 (Anticipated)
Study Completion Date
April 30, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Region Östergötland
Collaborators
Linkoeping University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The goal of this clinical trial is to learn about a new procedure for investigation of possible coronary heart disease and to see if it is faster, cheaper or more expensive, promotes healthier behavior, mental well-being, adherence to drugs for heart protection and the risk for cardiac events like acute myocardial infarction over years to come. The novelty in the procedure is that a myocardial perfusion scan to assess blood flow to areas of the heart muscle, echocardiography i.e., heart ultrasound and heart CT scan comes as a "package investigation" performed on the same day. According to existing routines, "standard investigation" an exercise stress bicycle test is done, as well as an echocardiography and if needed the work up is completed by a myocardial perfusion scan. The main questions the trial aims to answer are: are the results from the procedure given to the patient faster with package investigation as compared to standard investigation? does the cost differ between the package and standard investigation group? does self-reported physical activity, physical fitness, dietary habits and mental well-being differ between the package and standard investigation group at start and after one, three and five years? does prescription of drugs taken for heart protection and adherence to the prescribed drugs differ between the package and standard investigation group after two and five years? does the risk for heart events like acute heart infarction differ between package and standard investigation after two and five years? Primary health care centers in Region Östergötland are randomly assigned to use either the new or existing procedure for investigation of possible coronary heart disease a so called cluster randomization. Patients who consult a physician at any of these primary health care centers are potential participants in the trial and are informed about the trial by written information, as they get their appointment for the medical investigation at either of two hospitals in the Region Östergötland. When the patient comes to the hospital for the investigations, he or she is asked to give written consent to the research i.e., to answer questionnaires now after one, three and five years, to let the researchers take part of the medical records, investigational results and data from medical registries over time.
Detailed Description
In primary health care patients with chest symptoms are common. In many cases the cause is benign but chronic coronary artery disease (CAD) must often be considered. In the clinical work, evaluation of symptoms and risk factors are fundamental for a plausible working diagnosis and to judge if any further investigation is needed. The probability of CAD for a person of a certain age, sex and character of chest symptoms, scored from 0-3, i.e. pretest probability (PTP) for CAD, is substantially lower now than it was a decade ago in western countries. Consequently, recent European guidelines recommend that further investigation to rule out CAD may be omitted if the risk for CAD is judged to be low (PTP<15 %) and there are no further cardiovascular risk factors. If further investigation is needed in the low-risk group, computed tomography angiography (CTA) is preferable. When the risk for CAD is judged to be intermediate (PTP> 15 %) an imaging investigation is advocated instead of the well-established exercise stress bicycle test. A much-used imaging test is myocardial perfusion scan in which an exercise stress bicycle test is performed, with the addition of an intravenous injection of a small amount of radioactive tracer, whereafter the myocardial blood flow is demonstrated by imaging. Sensitivity for myocardial perfusion scan to detect significant CAD is 87 % (95 % CI 83-90) in comparison with exercise stress bicycle test where it is only 58 % (95 % CI 46-69). Specificity is 70 % (95 % CI 63-76) and 62 (95 % CI 54-69) respectively. However, the exercise stress bicycle test reveals indirect signs of myocardial ischemia and is reasonable in price, easy to perform and available in many clinics and hospitals. It is since long the first-line method for referral from the primary care setting. If the result from the exercise stress bicycle test is inconclusive, the work-up should be continued, e.g. with myocardial perfusion scan. An echocardiogram is often performed as well to evaluate the condition of the myocardium, heart valves and left ventricular ejection fraction. This stepwise or sequential clinical work-up strategy is well known and reasonable in general practice where patients in general have a low prevalence of serious diseases compared to organ specialist clinics. Since June 2021 in Region Östergötland (471 912 inhabitants 2022) CTA is recommended if further investigation is deemed necessary in patients with a low risk of CAD (PTP< 15 %) in primary care. For patients with intermediate risk of CAD (PTP> 15 %) exercise stress bicycle test is still the first-line choice. There may be advantages if myocardial perfusion scan and echocardiogram is performed on a single visit. In addition, a CT scan of the heart to determine coronary artery calcification (CAC) score is easy to perform on the same visit, gives only a small amount of radiation and adds useful information. The CAC-score has been shown to be an independent predictor of future cardiovascular events and is useful for reclassification of cardiovascular risk based on traditional risk factors like age, cholesterol levels and smoking habits. Furthermore, a clear and coherent answer on all three investigations, to the referring GP can provide a more secure basis for clinical decision making. For the individual patient it is probably an advantage to get a thorough investigation done at one single visit and possibly a faster and more valid statement from the investigations by the GP. On the other hand, if many advanced investigations are done unnecessarily, expenses and exposure to radiation will increase unjustifiably. Possibly there is also a risk of medicalization and to create worries for future cardiovascular events communicating the CAC-score to people that has not asked for the information. In order to get a faster and more complete basis for the evaluation of CAD in primary care patients with an intermediate (PTP> 15 %) risk the investigators created a package investigation comprised of myocardial perfusion scan, echocardiogram and CT scan of the heart on a single visit. The results from myocardial perfusion scan will be written according to national guidelines and communicated to the referring GP together with results from echocardiogram and CAC-scoring as a coherent answer. Moreover, registration of heart sounds followed by risk calculation by a technical device Cadscore® will be performed but only for scientific analyzes and not be given as a clinical answer. In this study the investigators aim to compare the standard routine sequential investigation for detecting CAD with a single-visit package investigation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease
Keywords
Primary Health Care, Diagnostic Imaging, Myocardial Perfusion Imaging

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Cluster randomised trial. All of 47 primary health care centres in Region Östergötland are invited to take part. After acceptance the actual number of primary health care centres will be randomly allocated to to either package or standard investigation group. The aim is to include about 20 primary health care centers in the study.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
500 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Package investigation
Arm Type
Experimental
Arm Description
Resting ECG, Evaluation of risk according to PTP-table. Echocardiography, Exercise stress bicycle test (secondarily drug provocation) with injection of isotope for myocardial scintigraphy, Scanning for myocardial perfusion CAC-scoring with CT
Arm Title
Standard investigation
Arm Type
Active Comparator
Arm Description
Resting ECG Evaluation of risk according to PTP-table. Echocardiography. Exercise stress bicycle test. If judged to be needed according to clinical indication sequentially completed by: Echocardiography, Exercise stress bicycle test (secondarily drug provocation) with injection of isotope for myocardial scintigraphy and/or Coronary CTA. In addition, cardiac examinations done with other modalities chosen on clinical grounds will be examined in the study. ,
Intervention Type
Diagnostic Test
Intervention Name(s)
Package investigation
Intervention Description
Investigations performed on a single visit, according to arm description
Intervention Type
Device
Intervention Name(s)
Sound registration with Cadscore® and added risk calculation
Intervention Description
Recording of cardiac diastolic sounds enabling the calculation of a risk score.
Intervention Type
Diagnostic Test
Intervention Name(s)
Standard investigation
Intervention Description
Sequential investigations according to arm description
Primary Outcome Measure Information:
Title
Number of days till completed assessment of myocardial ischemia
Description
waiting time (days) after the results of package investigation or exercise stress bicycle test (standard investigation) are available at the primary health care center till invasive coronary angiography is done or results from completed non-invasive myocardial ischemia investigation is communicated to the participant (patient).
Time Frame
From the day of inclusion up to one year
Secondary Outcome Measure Information:
Title
Swedish crowns or other currency
Description
Costs for medical investigations, consultations and costs generated by participants loss of production and travel costs. Data will be gathered by review of the participants computerized medical records one year after the day of inclusion. Medical investigations will be sought in local medical registries.The participant will be asked if being a professional worker or not on the day of inclusion.
Time Frame
From the day of inclusion and one year thereafter
Title
Health related quality of life
Description
Health related quality of life will be measured by EQ-5D-5L Swedish version (Devlin NJ et al., 2017)
Time Frame
Up to five years
Title
Radiation per patient
Description
millisievert (mSv)
Time Frame
One year
Title
Physical activity
Description
Physical activity will be measured by two categorical questions asking for level of physical activity (Olsson SJ et al., 2016)
Time Frame
Up to five years
Title
Dietary habits
Description
Dietary habits will be measured by five categorical questions about consumption of fruit, vegetables, snacks and soft drinks during the last week. (Henriksson H et al., 2020)
Time Frame
Up to five years
Title
Health and life quality
Description
Health and life quality will be measured by the Swedish RAND-36 A 36-item scale. (Ohlsson-Nevo E et al., 2021)
Time Frame
Up to five years
Title
Heart focused anxiety
Description
Heart focused anxiety will be measured by the Cardiac Anxiety Questionnaire - CAQ An 18-item scale (Eifert et al., 2000)
Time Frame
Up to five years
Title
Generalized anxiety
Description
Generalized anxiety will be measured by the Brief Measure for Assessing Generalized Anxiety Disorder - GAD-7 A seven item scale. (Spitzer et al., 2006)
Time Frame
Up to five years
Title
Depression symptoms
Description
Depression symptoms will be measured by the Patient Health Questionnaire - PHQ-9 Maximum score 27 (Hansson et al., 2009)
Time Frame
Up to five years
Title
Sleep quality
Description
Sleep quality will be measured by The Pittsburgh Sleep Quality Index - PSQI A 19-item scale which assesses sleep quality and disturbances over a 1-month time interval. (Buysse et al., 1989)
Time Frame
Up to five years
Title
Physical fitnes
Description
Physical fitness will be measured by The International Fitness Scale - IFIS A 5-item scale (Ortega FB et al., 2011)
Time Frame
Up to five years
Title
MACE
Description
Major adverse cardiovascular event - MACE Data will be gathered from national Swedish registries i.e. SWEDEHEART, the National Patient Register and Dödsorsaksregistret (The Cause of Death Register)
Time Frame
Up to five years
Title
Compliance to cardioprotective drugs
Description
Data on prescribed and purchased drugs will be gathered from the National Prescribed Drug Register .
Time Frame
Two years before and up to five years after inclusion.
Other Pre-specified Outcome Measures:
Title
Presence of pathological q-waves
Description
Resting ECG
Time Frame
On the day of inclusion
Title
Reversible ischemia
Description
ST-depression provoked by exercise
Time Frame
On the day of inclusion
Title
Alcohol consumption
Description
Alcohol consumption will be measured by the Alcohol Use Disorders Identification Test - AUDIT. Score range: 0-40. (WHO-publications 2001)
Time Frame
Up to five years
Title
Smoking
Description
Smoking will be measured by the question 'Do you smoke?' (No, I have never smoked/No, I have quitted/Yes, occasionally/Yes, daily) and quantified by the number of cigarettes per day.
Time Frame
Up to five years
Title
Dental health
Description
Dental health will be explored by a 5-item questionnaire constructed for the study
Time Frame
Up to five years
Title
Number of days on sick leave
Description
Data will be gathered by review of the participants computerized medical records one year after the day of inclusion.
Time Frame
Time frame: From the day of inclusion and one year thereafter

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: • People who seek primary care for symptoms judged to be compatible with a medium probability (PTP> 15) for symptomatic chronic coronary artery disease. Exclusion Criteria: Suspicion of acute coronary syndrome when care is sought. Previously diagnosed acute myocardial infarction Revascularization with PCI/CABG Proven reversible ischemia according to myocardial scintigraphy. Left Bundle Branch Block (LBBB). Ventricular pacemaker People whose meaning due to illness, mental disorder, weakened state of health or any other similar condition cannot be obtained, to be included in a research project. Insufficient understanding of spoken and written Swedish language.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Staffan Nilsson, MD PhD
Phone
+46101030000
Email
staffan.g.nilsson@liu.se
First Name & Middle Initial & Last Name or Official Title & Degree
Fredrik Iredahl, MD, PhD
Phone
+46101030000
Email
fredrik.iredahl@liu.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Staffan Nilsson, MD, PhD
Organizational Affiliation
IMH/Community Medicine/Linkoping university
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Clinical Physiology, Linköping University Hospital, Linköping
City
Linköping
ZIP/Postal Code
S-58185
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jan Engvall, Professor
Email
jan.engvall@liu.se
Facility Name
Hjärthälsan Linköping AB
City
Linköping
ZIP/Postal Code
S-582 18
Country
Sweden
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carlos Valadares, MD
Email
kontakt@hhalsan.se
Facility Name
Department of Clinical Physiology, Vrinnevi Hospital
City
Norrköping
ZIP/Postal Code
S-601 82
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karin Pejic, MD
Email
Karin.Pejic@regionostergotland.se

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31504439
Citation
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425. No abstract available. Erratum In: Eur Heart J. 2020 Nov 21;41(44):4242.
Results Reference
background
PubMed Identifier
28634285
Citation
Hoorweg BB, Willemsen RT, Cleef LE, Boogaerts T, Buntinx F, Glatz JF, Dinant GJ. Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses. Heart. 2017 Nov;103(21):1727-1732. doi: 10.1136/heartjnl-2016-310905. Epub 2017 Jun 20.
Results Reference
background
PubMed Identifier
29850808
Citation
Knuuti J, Ballo H, Juarez-Orozco LE, Saraste A, Kolh P, Rutjes AWS, Juni P, Windecker S, Bax JJ, Wijns W. The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability. Eur Heart J. 2018 Sep 14;39(35):3322-3330. doi: 10.1093/eurheartj/ehy267.
Results Reference
background
PubMed Identifier
30982851
Citation
Juarez-Orozco LE, Saraste A, Capodanno D, Prescott E, Ballo H, Bax JJ, Wijns W, Knuuti J. Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease. Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1198-1207. doi: 10.1093/ehjci/jez054.
Results Reference
background
PubMed Identifier
29122932
Citation
Winther S, Nissen L, Schmidt SE, Westra JS, Rasmussen LD, Knudsen LL, Madsen LH, Kirk Johansen J, Larsen BS, Struijk JJ, Frost L, Holm NR, Christiansen EH, Botker HE, Bottcher M. Diagnostic performance of an acoustic-based system for coronary artery disease risk stratification. Heart. 2018 Jun;104(11):928-935. doi: 10.1136/heartjnl-2017-311944. Epub 2017 Nov 9.
Results Reference
background
PubMed Identifier
29688297
Citation
Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, Kronmal R, Lima JAC, Liu KJ, McClelland RL, Michos E, Post WS, Shea S, Watson KE, Wong ND. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J. 2018 Jul 1;39(25):2401-2408. doi: 10.1093/eurheartj/ehy217.
Results Reference
background
PubMed Identifier
30409567
Citation
Mitchell JD, Fergestrom N, Gage BF, Paisley R, Moon P, Novak E, Cheezum M, Shaw LJ, Villines TC. Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring. J Am Coll Cardiol. 2018 Dec 25;72(25):3233-3242. doi: 10.1016/j.jacc.2018.09.051.
Results Reference
background
PubMed Identifier
28194657
Citation
Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: Past, Present and Future. Appl Health Econ Health Policy. 2017 Apr;15(2):127-137. doi: 10.1007/s40258-017-0310-5.
Results Reference
background
PubMed Identifier
26392418
Citation
Olsson SJ, Ekblom O, Andersson E, Borjesson M, Kallings LV. Categorical answer modes provide superior validity to open answers when asking for level of physical activity: A cross-sectional study. Scand J Public Health. 2016 Feb;44(1):70-6. doi: 10.1177/1403494815602830. Epub 2015 Sep 21.
Results Reference
background
PubMed Identifier
33228572
Citation
Henriksson H, Alexandrou C, Henriksson P, Henstrom M, Bendtsen M, Thomas K, Mussener U, Nilsen P, Lof M. MINISTOP 2.0: a smartphone app integrated in primary child health care to promote healthy diet and physical activity behaviours and prevent obesity in preschool-aged children: protocol for a hybrid design effectiveness-implementation study. BMC Public Health. 2020 Nov 23;20(1):1756. doi: 10.1186/s12889-020-09808-w.
Results Reference
background
PubMed Identifier
34347192
Citation
Ohlsson-Nevo E, Hiyoshi A, Noren P, Moller M, Karlsson J. The Swedish RAND-36: psychometric characteristics and reference data from the Mid-Swed Health Survey. J Patient Rep Outcomes. 2021 Aug 4;5(1):66. doi: 10.1186/s41687-021-00331-z.
Results Reference
background
PubMed Identifier
11004742
Citation
Eifert GH, Thompson RN, Zvolensky MJ, Edwards K, Frazer NL, Haddad JW, Davig J. The cardiac anxiety questionnaire: development and preliminary validity. Behav Res Ther. 2000 Oct;38(10):1039-53. doi: 10.1016/s0005-7967(99)00132-1.
Results Reference
background
PubMed Identifier
16717171
Citation
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.
Results Reference
background
PubMed Identifier
19761655
Citation
Hansson M, Chotai J, Nordstom A, Bodlund O. Comparison of two self-rating scales to detect depression: HADS and PHQ-9. Br J Gen Pract. 2009 Sep;59(566):e283-8. doi: 10.3399/bjgp09X454070.
Results Reference
background
PubMed Identifier
2748771
Citation
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.
Results Reference
background
PubMed Identifier
21441238
Citation
Ortega FB, Ruiz JR, Espana-Romero V, Vicente-Rodriguez G, Martinez-Gomez D, Manios Y, Beghin L, Molnar D, Widhalm K, Moreno LA, Sjostrom M, Castillo MJ; HELENA study group. The International Fitness Scale (IFIS): usefulness of self-reported fitness in youth. Int J Epidemiol. 2011 Jun;40(3):701-11. doi: 10.1093/ije/dyr039. Epub 2011 Mar 24.
Results Reference
background
Links:
URL
https://www.ucr.uu.se/swedeheart/
Description
SWEDEHEART
URL
https://www.socialstyrelsen.se/en/statistics-and-data/registers/national-patient-register/
Description
The National Patient Register
URL
https://www.socialstyrelsen.se/statistik-och-data/register/dodsorsaksregistret/
Description
Dödsorsaksregistret (The Cause of Death Register)
URL
https://www.socialstyrelsen.se/en/statistics-and-data/registers/national-prescribed-drug-register/
Description
The National Prescribed Drug Register

Learn more about this trial

Chronic Coronary Syndrome in Swedish Primary Care

We'll reach out to this number within 24 hrs